Single-photon Emission Computed Tomography (SPECT) to Predict Peritoneal Chemotherapy

Uppsala University

Status: Completed

Conditions: Peritoneal Carcinomatosis

Study type: Observational

Funder types: Other

Identifiers

NCT00997633

SPECT IK1991:5

Details and patient eligibility

About

SPECT was performed in 51 patients after cytoreductive surgery in combination with intraperitoneal chemotherapy. The detected volume was compared to the number of subsequent sequential postoperative intraperitoneal chemotherapy courses that could be performed without further surgical intervention. SPECT data was found to predict feasibility of sequential postoperative intraperitoneal chemotherapy.

Enrollment: 51 patients

Sex: All

Ages: 14 to 74 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Cytoreductive surgery and intraperitoneal chemotherapy
• Single-Photon Emission Computed Tomography (SPECT) before the second course of treatment

Trial design

51 participants in 1 patient group

Peritoneal carcinomatosis

Description:

Patients undergoing cytoreductive surgery and intraperitoneal chemotherapy treatment